Article Data

  • Views 1815
  • Dowloads 284

Reviews

Open Access Special Issue

Procedural sedation and analgesia in the pediatric intensive care unit

  • Ivana Budic1,2,*,
  • Vesna Marjanovic1,2
  • Ivona Djordjevic2,3
  • Marija Stevic4,5
  • Dragoljub Zivanovic2,3
  • Dusica Simic4,5

1Clinic for Anesthesiology and Intensive Care, University Clinical Centre Nis, 18000 Nis, Serbia

2Medical Faculty, University of Nis, 18000 Nis, Serbia

3Clinic for Children’s Surgery, University Clinical Centre Nis, 18000 Nis, Serbia

4University Children’s Hospital, 11000 Belgrade, Serbia

5Medical Faculty, University of Belgrade, 11000 Belgrade, Serbia

DOI: 10.22514/sv.2023.007 Vol.19,Issue 5,September 2023 pp.38-46

Submitted: 28 June 2022 Accepted: 30 August 2022

Published: 08 September 2023

(This article belongs to the Special Issue Pediatric Critical Care)

*Corresponding Author(s): Ivana Budic E-mail: md.ivanabudic@gmail.com

Abstract

Children frequently experience more painful, stressful, and traumatic medical procedures and treatments in the pediatric intensive care unit (PICU) than when they are hospitalized in general wards. An essential part of care in the PICU is providing critically ill children with appropriate sedation and analgesia. Finding the perfect combination of adequate analgesia and sufficient sedation in a patient group with a wide range of ages, sizes, and developmental stages can be challenging. Administration of sedatives and analgesics to critically ill patients may be challenging and complicated by unpredictable pharmacokinetics (PK) and pharmacodynamics (PD). It is important to keep in mind that optimal agents for procedural sedation and analgesia (PSA) differ from those used for long-term sedation in the PICU. In addition to pharmacological measures, different non-pharmacological methods can be applied and have been shown to be effective for pain relief in children. Efforts are being made to improve PSA management with the use of national surveys, recommendations, and guidelines.


Keywords

Procedural sedation; Procedural analgesia; Neonate; Child; Intensive care unit


Cite and Share

Ivana Budic,Vesna Marjanovic,Ivona Djordjevic,Marija Stevic,Dragoljub Zivanovic,Dusica Simic. Procedural sedation and analgesia in the pediatric intensive care unit. Signa Vitae. 2023. 19(5);38-46.

References

[1] Long D, Gibbons K, Le Brocque R, Schults JA, Kenardy J, Dow B. Midazolam exposure in the paediatric intensive care unit predicts acute post-traumatic stress symptoms in children. Australian Critical Care. 2022; 35: 408–414.

[2] Egbuta C, Mason KP. Current state of analgesia and sedation in the pediatric intensive care unit. Journal of Clinical Medicine. 2021; 10: 1847.

[3] Homma Y, Norii T, Kanazawa T, Hoshino A, Arino S, Takase H, et al. A mini‐review of procedural sedation and analgesia in the emergency department. Acute Medicine & Surgery. 2020; 7: e574.

[4] Aslam SL, Haque A, Jamil MT, Ariff M, Nasir S. Safety and Efficacy of Procedural Sedation and Analgesia in Pediatric Oncology Patients. Cureus. 2020; 12: e7442.

[5] Chawla N, Boateng A, Deshpande R. Procedural sedation in the ICU and emergency department. Current opinion in anesthesiology. 2017; 30: 507–512.

[6] Barnes S, Yaster M, Kudchadkar SR. Pediatric sedation management. Pediatrics in Review. 2016; 37: 203–212.

[7] Fagin A, Palmieri TL. Considerations for pediatric burn sedation and analgesia. Burns & Trauma. 2017; 5: 28.

[8] Thakkar N, Salerno S, Hornik CP, Gonzalez D. Clinical pharmacology studies in critically ill children. Pharmaceutical Research. 2017; 34: 7–24.

[9] Koizumi T, Kurosawa H. Survey of analgesia and sedation in pediatric intensive care units in Japan. Pediatrics International. 2020; 62: 535–541.

[10] LaFond CM, Hanrahan KS, Pierce NL, Perkhounkova Y, Laures EL, McCarthy AM. Pain in the pediatric intensive care unit: how and what are we doing? American Journal of Critical Care. 2019; 28: 265–273.

[11] Tabacco B, Tacconi C, Amigoni A. Survey on monitoring analgesia and sedation in the Italian pediatric intensive care units. Minerva Anestesiologica. 2017; 83: 1010–1016.

[12] Baarslag MA, Allegaert K, Knibbe CAJ, van Dijk M, Tibboel D. Pharmacological sedation management in the paediatric intensive care unit. Journal of Pharmacy and Pharmacology. 2017; 69: 498–513.

[13] Lam J, Baello S, Iqbal M, Kelly LE, Shannon PT, Chitayat D, et al. The ontogeny of P-glycoprotein in the developing human blood–brain barrier: implication for opioid toxicity in neonates. Pediatric Research. 2015; 78: 417–421.

[14] Ziesenitz VC, Vaughns JD, Koch G, Mikus G, van den Anker JN. Pharmacokinetics of fentanyl and its derivatives in children: a comprehensive review. Clinical Pharmacokinetics. 2018; 57: 125–149.

[15] Lu H, Rosenbaum S. Developmental pharmacokinetics in pediatric populations. The Journal of Pediatric Pharmacology and Therapeutics. 2014; 19: 262–276.

[16] MacKenzie M, Hall R. Pharmacogenomics and pharmacogenetics for the intensive care unit: a narrative review. Canadian Journal of Anesthesia. 2017; 64: 45–64.

[17] Vet NJ, Kleiber N, Ista E, de Hoog M, de Wildt SN. Sedation in critically ill children with respiratory failure. Frontiers in Pediatrics. 2016; 4: 89.

[18] Ramalho CE, Bretas PMC, Schvartsman C, Reis AG. Sedation and analgesia for procedures in the pediatric emergency room. Jornal De Pediatria. 2017; 93: 2–18.

[19] Andropoulos DB, Greene MF. Anesthesia and developing brains—implications of the FDA warning. New England Journal of Medicine. 2017; 376: 905–907.

[20] Zuppa AF, Curley MAQ. Sedation analgesia and neuromuscular blockade in pediatric critical care: overview and current landscape. Pediatric clinics of North America. 2017; 64: 1103–1116.

[21] Mody K, Kaur S, Mauer EA, Gerber LM, Greenwald BM, Silver G, et al. Benzodiazepines and development of delirium in critically ill children: estimating the causal effect. Critical Care Medicine. 2018; 46: 1486–1491.

[22] Smith HAB, Gangopadhyay M, Goben CM, Jacobowski NL, Chestnut MH, Thompson JL, et al. Delirium and benzodiazepines associated with prolonged ICU stay in critically ill infants and young children. Critical Care Medicine. 2017; 45: 1427–1435.

[23] Amigoni A, Conti G, Conio A, Corno M, Fazio PC, Ferrero F, et al. Recommendations for analgesia and sedation in critically ill children admitted to intensive care unit. Journal of Anesthesia, Analgesia and Critical Care. 2022; 2: 9.

[24] Zalieckas J, Weldon C. Sedation and analgesia in the ICU. Seminars in Pediatric Surgery. 2015; 24: 37–46.

[25] Kaye A, Urman R, Rappaport Y, Siddaiah H, Cornett E, Belani K, et al. Multimodal analgesia as an essential part of enhanced recovery protocols in the ambulatory settings. Journal of Anaesthesiology Clinical Pharmacology. 2019; 35: 40.

[26] Nasr VG, DiNardo JA. Sedation and analgesia in pediatric cardiac critical care. Pediatric Critical Care Medicine. 2016; 17: S225–S231.

[27] Zielinska M, Bartkowska-Sniatkowska A, Becke K, Höhne C, Najafi N, Schaffrath E, et al. Safe pediatric procedural sedation and analgesia by anesthesiologists for elective procedures: a clinical practice statement from the European Society for Paediatric Anaesthesiology. Pediatric Anesthesia. 2019; 29: 583–590.

[28] Foo TY, Mohd Noor N, Yazid MB, Fauzi MH, Abdull Wahab SF, Ahmad MZ. Ketamine-propofol (Ketofol) for procedural sedation and analgesia in children: a systematic review and meta-analysis. BMC Emergency Medicine. 2020; 20: 81.

[29] Hazwani TR, Alem HA. Procedural moderate sedation with ketamine in pediatric critical care unit. Avicenna Journal of Medicine. 2017; 07: 7–11.

[30] Karnjus I, Mekis D, Krizmaric M. Inhalation sedation with the ‘Anaesthetic Conserving Device’ for patients in intensive care units: a literature review. Signa Vitae. 2016; 11: 1–24.

[31] Jung C, Granados M, Marsol P, Murat I, Gall O. Use of sevoflurane sedation by the AnaConDa® device as an adjunct to extubation in a pediatric burn patient. Burns. 2008; 34: 136–138.

[32] Mudd S. Intranasal fentanyl for pain management in children: a systematic review of the literature. Journal of Pediatric Health Care. 2011; 25: 316–22.

[33] Lane RD, Schunk JE. Atomized intranasal midazolam use for minor procedures in the pediatric emergency department. Pediatric Emergency Care. 2008; 24: 300–303.

[34] Conway A, Rolley J, Sutherland JR. Midazolam for sedation before procedures. The Cochrane Database of Systematic Reviews. 2016; 2016: CD009491.

[35] Pansini V, Curatola A, Gatto A, Lazzareschi I, Ruggiero A, Chiaretti A. Intranasal drugs for analgesia and sedation in children admitted to pediatric emergency department: a narrative review. Annals of Translational Medicine. 2021; 9: 189–189.

[36] Poonai N, Spohn J, Vandermeer B, Ali S, Bhatt M, Hendrikx S, et al. Intranasal dexmedetomidine for procedural distress in children: a systematic review. Pediatrics. 2020; 145: e20191623.

[37] Poonai N, Canton K, Ali S, Hendrikx S, Shah A, Miller M, et al. Intranasal ketamine for procedural sedation and analgesia in children: a systematic review. PLoS One. 2017; 12: e0173253.

[38] Milési C, Baleine J, Mura T, Benito-Castro F, Ferragu F, Thiriez G, et al. Nasal midazolam vs. ketamine for neonatal intubation in the delivery room: a randomised trial. Archives of Disease in Childhood-Fetal and Neonatal Edition. 2018; 103: F221–F226.

[39] Mangat AK, Oei JL, Chen K, Quah-Smith I, Schmölzer GM. A review of non-pharmacological treatments for pain management in newborn infants. Children. 2018; 5: 130.

[40] Bucsea O, Pillai Riddell R. Non-pharmacological pain management in the neonatal intensive care unit: managing neonatal pain without drugs. Seminars in Fetal and Neonatal Medicine. 2019; 24: 101017.

[41] Bohr NL, Ely E, Hanrahan KS, McCarthy AM, LaFond CM. Predicting who receives nonpharmacologic pain interventions in the pediatric intensive care unit. Pain Management Nursing. 2022; 23: 267–272.

[42] Riddell RP, Racine N, Turcotte K, Uman LS, Horton R, Osmun LD, et al. Nonpharmacological management of procedural pain in infants and young children: an abridged cochrane review. Pain Research and Management. 2011; 16: 321–330.

[43] Bueno M, Yamada J, Harrison D, Khan S, Ohlsson A, Adams-Webber T, et al. A systematic review and meta-analyses of nonsucrose sweet solutions for pain relief in neonates. Pain Research and Management. 2013; 18: 153–161.

[44] Stevens B, Yamada J, Ohlsson A, Haliburton S, Shorkey A. Sucrose for analgesia in newborn infants undergoing painful procedures. The Cochrane Database of Systematic Reviews. 2016; 7: CD001069.

[45] Vu-Ngoc H, Uyen NCM, Thinh OP, Don LD, Danh NVT, Truc NTT, et al. Analgesic effect of non-nutritive sucking in term neonates: a randomized controlled trial. Pediatrics & Neonatology. 2020; 61: 106–113.

[46] Shah PS, Herbozo C, Aliwalas LL, Shah VS. Breastfeeding or breast milk for procedural pain in neonates. The Cochrane Database of Systematic Reviews. 2012; 12: CD004950.

[47] Akcan E, Yiğit R, Atici A. The effect of kangaroo care on pain in premature infants during invasive procedures. The Turkish Journal of Pediatrics. 2009; 51: 14–18.

[48] Johnston C, Campbell-Yeo M, Fernandes A, Inglis D, Streiner D, Zee R. Skin-to-skin care for procedural pain in neonates. The Cochrane Database of Systematic Reviews. 2014; 23: CD008435.

[49] Avila-Alvarez A, Carbajal R, Courtois E, Pertega-Diaz S, Muñiz-Garcia J, Anand KJS. Sedation and analgesia practices among Spanish neonatal intensive care units. An Pediatr. 2015; 83: 75–84.

[50] Carbajal R. Epidemiology and treatment of painful procedures in neonates in intensive care units. JAMA. 2008; 300: 60.

[51] Vinall J, Miller SP, Bjornson BH, Fitzpatrick KPV, Poskitt KJ, Brant R, et al. Invasive procedures in preterm children: brain and cognitive development at school age. Pediatrics. 2014; 133: 412–421.

[52] Grunau RE, Whitfield MF, Petrie-Thomas J, Synnes AR, Cepeda IL, Keidar A, et al. Neonatal pain, parenting stress and interaction, in relation to cognitive and motor development at 8 and 18 months in preterm infants. Pain. 2009; 143: 138–146.

[53] Anand KJ, Palmer FB, Papanicolaou AC. Repetitive neonatal pain and neurocognitive abilities in ex-preterm children. Pain. 2013; 154: 1899–1901.

[54] Zwicker JG, Grunau RE, Adams E, Chau V, Brant R, Poskitt KJ, et al. Score for neonatal acute physiology-II and neonatal pain predict corticospinal tract development in premature newborns. Pediatric Neurology. 2013; 48:123–129.e1.

[55] Puntillo KA, Max A, Timsit J, Vignoud L, Chanques G, Robleda G, et al. Determinants of procedural pain intensity in the intensive care unit. The Europain® study. American Journal of Respiratory and Critical Care Medicine. 2014; 189: 39–47.

[56] Kothari SY, Dongara AR, Nimbalkar SM, Phatak AG, Nimbalkar AS. Missed opportunities for sedation and pain management at a level III neonatal intensive care unit, India. Frontiers in Pediatrics. 2016; 4: 7.

[57] Assefa E, Dinkiye M, Geleta T, Tantu T, Wondwosen M, Zewdu D. The practice of procedural pain assessment and management in neonatal intensive care unit in Ethiopia: cross-sectional study. Health Science Reports. 2022; 5: e533.

[58] Courtois E, Cimerman P, Dubuche V, Goiset M, Orfèvre C, Lagarde A, et al. The burden of venipuncture pain in neonatal intensive care units: EPIPPAIN 2, a prospective observational study. International Journal of Nursing Studies. 2016; 57: 48–59.

[59] Cruz MD, Fernandes AM, Oliveira CR. Epidemiology of painful procedures performed in neonates: a systematic review of observational studies. European Journal of Pain. 2016; 20: 489–498.

[60] Debillon T, Bureau V, Savagner C, Zupan-Simunek V, Carbajal R. Pain management in French neonatal intensive care units. Acta Paediatrica. 2002; 91: 822–826.

[61] McKechnie L, Levene M. Procedural pain guidelines for the newborn in the United Kingdom. Journal of Perinatology. 2008; 28: 107–111.

[62] Harrison D, Loughnan P, Johnston L. Pain assessment and procedural pain management practices in neonatal units in Australia. Journal of Paediatrics and Child Health. 2006; 42: 6–9.

[63] Lago P, Guadagni A, Merazzi D, Ancora G, Bellieni CV, Cavazza A. Pain management in the neonatal intensive care unit: a national survey in Italy. Pediatric Anesthesia. 2005; 15: 925–931.

[64] Gharavi B, Schott C, Nelle M, Reiter G, Linderkamp O. Pain management and the effect of guidelines in neonatal units in Austria, Germany and Switzerland. Pediatrics International. 2007; 49: 652–658.

[65] Mehler K, Oberthuer A, Haertel C, Herting E, Roth B, Goepel W. Use of analgesic and sedative drugs in VLBW infants in German NICUs from 2003–2010. European Journal of Pediatrics. 2013; 172: 1633–1639.

[66] Eriksson M, Gradin M. Pain management in Swedish neonatal units—a national survey. Acta Paediatrica. 2008; 97: 870–874.

[67] Guedj R, Danan C, Daoud P, Zupan V, Renolleau S, Zana E, et al. Does neonatal pain management in intensive care units differ between night and day? An observational study. BMJ Open. 2014; 4: e004086.

[68] Lago P, Frigo AC, Baraldi E, Pozzato R, Courtois E, Rambaud J, et al. Sedation and analgesia practices at Italian neonatal intensive care units: results from the EUROPAIN study. Italian Journal of Pediatrics. 2017; 43: 26.

[69] Schechter NL, Finley GA, Bright NS, Laycock M, Forgeron P. ChildKind: a global initiative to reduce pain in children. Pediatric Pain Letter. 2010; 12: 26–30.

[70] Green SM, Mason KP, Krauss BS. Pulmonary aspiration during procedural sedation: a comprehensive systematic review. British Journal of Anaesthesia. 2017; 118: 344–354.

[71] Mason KP. Challenges in paediatric procedural sedation: political, economic, and clinical aspects. British Journal of Anaesthesia. 2014; 11: ii48–62.


Abstracted / indexed in

Science Citation Index Expanded (SciSearch) Created as SCI in 1964, Science Citation Index Expanded now indexes over 9,200 of the world’s most impactful journals across 178 scientific disciplines. More than 53 million records and 1.18 billion cited references date back from 1900 to present.

Journal Citation Reports/Science Edition Journal Citation Reports/Science Edition aims to evaluate a journal’s value from multiple perspectives including the journal impact factor, descriptive data about a journal’s open access content as well as contributing authors, and provide readers a transparent and publisher-neutral data & statistics information about the journal.

Chemical Abstracts Service Source Index The CAS Source Index (CASSI) Search Tool is an online resource that can quickly identify or confirm journal titles and abbreviations for publications indexed by CAS since 1907, including serial and non-serial scientific and technical publications.

Index Copernicus The Index Copernicus International (ICI) Journals database’s is an international indexation database of scientific journals. It covered international scientific journals which divided into general information, contents of individual issues, detailed bibliography (references) sections for every publication, as well as full texts of publications in the form of attached files (optional). For now, there are more than 58,000 scientific journals registered at ICI.

Geneva Foundation for Medical Education and Research The Geneva Foundation for Medical Education and Research (GFMER) is a non-profit organization established in 2002 and it works in close collaboration with the World Health Organization (WHO). The overall objectives of the Foundation are to promote and develop health education and research programs.

Scopus: CiteScore 1.0 (2022) Scopus is Elsevier's abstract and citation database launched in 2004. Scopus covers nearly 36,377 titles (22,794 active titles and 13,583 Inactive titles) from approximately 11,678 publishers, of which 34,346 are peer-reviewed journals in top-level subject fields: life sciences, social sciences, physical sciences and health sciences.

Embase Embase (often styled EMBASE for Excerpta Medica dataBASE), produced by Elsevier, is a biomedical and pharmacological database of published literature designed to support information managers and pharmacovigilance in complying with the regulatory requirements of a licensed drug.

Submission Turnaround Time

Conferences

Top